Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be attending ESMO Conference, October 20 – 24 in Madrid, Spain. They are excited to interact with key leaders, clinicians, researchers, and patient advocates from all over world to learn and brainstorm about the latest in oncology research and treatments.